John Boslego, MD, has been named senior vice president and head of development for Takeda’s Global Vaccine Business Unit, effective December 1, 2014. He’ll succeed Ralf Clemens, MD, who held the role since the launch of the Vaccine Division in January 2012.   Dr. Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programs for dengue, norovirus and seasonal flu. He will report to Rajeev Venkayya, MD, president of Takeda’s Global Vac...